Results 91 to 100 of about 4,774 (193)

Emerging Role of Gut Microbiota in Modulating Response to Therapies in IBD. [PDF]

Microorganisms
Bartocci B, Del Gaudio A, Murgiano M, Papa A, Cammarota G, Gasbarrini A, Scaldaferri F, Lopetuso LR.   +7 more
europepmc   +1 more source

Significant kidney impairment in pediatric inflammatory bowel disease and practice points for pediatric gastroenterologists. [PDF]

J Pediatr Gastroenterol Nutr
Vuijk SA, Klomberg RCW, Schwerd T, Griffiths AM, Hussey S, Carroll MW, Malmborg P, Deb P, Wessels M, Mouratidou N, van Biervliet S, Friedt M, Minson S, Vrieling-Prince FHM, Croft NM, de Ridder L, PIBD‐SETQuality Safety Registry Collaborative Group.   +16 more
europepmc   +1 more source

Drug Exposure Dictates Evolutionary Dynamics of Drug-Resistant Tuberculosis: A Longitudinal Cohort Study in Beijing, China. [PDF]

Infect Drug Resist
Wen S, Li H, Shi Y, Wei R, Ge F, Pang Y, Liu Y.   +6 more
europepmc   +1 more source

A Comprehensive Review of Genetic Mechanisms of <i>Mycobacterium tuberculosis</i> Resistance to Injectable Agents, Second-Line Drugs, and Novel Therapeutics. [PDF]

Infect Drug Resist
Roshdi Maleki M.
europepmc   +1 more source

Navigating a thorny path: oral nanomedicines for the precision management of radiation-induced intestinal injury. [PDF]

J Nanobiotechnology
Yu B, Zhang J, Tang Y, Zou Y, Xu H, Yang M, Xu K, Yu J, Miao YB, Du X.   +9 more
europepmc   +1 more source

Enterohemorrhagic <i>Escherichia coli</i> senses colonic oxygen availability to modulate its virulence and colonization. [PDF]

iScience
Fang F, Li Y, Zhong Y, Xu X, Ouyang T, Han J, Dou L, Xue Y, Wang D.   +8 more
europepmc   +1 more source

Disease Burden and Unmet Medical Needs in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey. [PDF]

Med Sci (Basel)
Gourzoulidis G, Vakouftsi VR, Mavridoglou G, Psarra M, Tzanetakos C.   +4 more
europepmc   +1 more source

Ulcerative colitis: signaling pathways, therapeutic targets and interventional strategies. [PDF]

Signal Transduct Target Ther
Jia J, Liu Y, Wang D, Pan Z, Zheng Q, Lu J, Liang C, Li D.   +7 more
europepmc   +1 more source

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis

, 2003
Berlanga-Acosta, J, Sinha, A, West, KP, Playford, RJ, Nightingale, JMD   +4 more
core  

Biomarkers of Probiotic Therapy in Ulcerative Colitis: A Systematic Review of Mechanisms Underlying Remission. [PDF]

Cureus
Farhad ME, Belal I, Baana M, Childs C, Al-Rufayie M.   +4 more
europepmc   +1 more source